Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a ...
Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...
The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more ...
Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...
Between condoms and vasectomies lies a vast, undeveloped chasm of male birth control. Contraline, a device startup that released early, positive clinical data in a press release on Thursday, hopes to ...
NEW YORK (Reuters Health) - Injectable birth control is known to lower bone density, but women may be able to limit the loss by not smoking and getting even moderate amounts of calcium, a new study ...
U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...
A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...
The multidistrict litigation over the injectable birth control totals more than 100 lawsuits against Pfizer Inc. but could reach into the thousands. The interviews, which could stretch into Friday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results